Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CAD | 0.00% |
|
-6.25% | +15.38% |
26/06 | Transcript : MediPharm Labs Corp. - Shareholder/Analyst Call | |
20/06 | MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 2.22Cr | |
+26.93% | 559.76Cr | |
-33.55% | 353.05Cr | |
-3.74% | 302.97Cr | |
-26.09% | 258.15Cr | |
-10.93% | 230.75Cr | |
+41.50% | 185.97Cr | |
+41.84% | 144.94Cr | |
+47.62% | 141.07Cr | |
-28.07% | 126.88Cr |
- Stock Market
- Equities
- LABS Stock
- News MediPharm Labs Corp.
- MediPharm Labs to Acquire Rights for Advanced Medical Cannabis Products From Remidose Aerosols